Maccura Biotechnology Co.Ltd (300463.SZ)

CNY 13.88

(0.51%)

Market Cap (In CNY)

8.5 Billion

Revenue (In CNY)

2.89 Billion

Net Income (In CNY)

312.61 Million

Avg. Volume

6.9 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.9-17.31
PE
-
EPS
-
Beta Value
0.375
ISIN
CNE1000020H3
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Wu Mingjian
Employee Count
-
Website
https://www.maccura.com
Ipo Date
2015-05-28
Details
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers. It also provides SARS-COV-2(COVID-19) products that includes nucleic acid detection kit and other products; glucometers; POCT products, such as fluorescence immunoassay analyzers, as well as colloidal gold kits; molecular diagnosis products, such as PCR kit; and pathology products. The company was incorporated in 1994 and is based in Chengdu, China.